Pancreatic Cancer Research

ResearcherHeidelberg UniversityNo recent work listed

Moritz Koch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8358-8916; OpenAlex author ID A5106499736. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2011: 4 papers · 2012: 2 papers · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper

Papers 9

  1. Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts. Co-author DOI 10.15252/emmm.201607354↗
  2. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. Co-author DOI 10.1074/jbc.c113.532267↗
  3. Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer. Last author DOI 10.18632/oncotarget.2651↗
  4. AB0 blood group and prognosis in patients with pancreatic cancer. Co-author DOI 10.1186/1471-2407-12-319↗
  5. Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients… Co-author DOI 10.1186/1471-2407-12-361↗
  6. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1097/sla.0b013e31823ac299↗
  7. Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer. Co-author DOI 10.1186/1471-2407-11-134↗
  8. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. Co-author DOI 10.1186/1471-2407-11-275↗
  9. Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer. Last author DOI 10.1186/1471-2407-11-286↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jürgen Weitz · 7 shared papers, 2011–2017 · strength 0.21
  2. Nuh N. Rahbari · 4 shared papers, 2011–2014 · strength 0.12
  3. Markus Wolfgang Büchler · 4 shared papers, 2011–2012 · strength 0.11
  4. Christoph Kahlert · 3 shared papers, 2011–2014 · strength 0.10
  5. Jens Werner · 2 shared papers, 2011–2017 · strength 0.07
  6. Thomas Schmidt · 2 shared papers, 2011–2014 · strength 0.06
  7. Karl Roland Ehrenberg · 1 shared paper, 2017 · strength 0.05
  8. Wilko Weichert · 1 shared paper, 2017 · strength 0.05
  9. Claudia R. Ball · 1 shared paper, 2017 · strength 0.05
  10. Hanno Glimm · 1 shared paper, 2017 · strength 0.05
  11. Philipp Beckhove · 2 shared papers, 2011–2012 · strength 0.05
  12. Jianhua Zhang · 1 shared paper, 2014 · strength 0.04
  13. Phillip Andrew Futreal · 1 shared paper, 2014 · strength 0.04
  14. Raghu Kalluri · 1 shared paper, 2014 · strength 0.04
  15. Lynda Chin · 1 shared paper, 2014 · strength 0.04
  16. Sónia A. Melo · 1 shared paper, 2014 · strength 0.04
  17. Martin A. Schneider · 1 shared paper, 2014 · strength 0.03
  18. Massimiliano Mazzone · 1 shared paper, 2014 · strength 0.03
  19. Mathieu Pecqueux · 1 shared paper, 2014 · strength 0.03
  20. Niels Halama · 1 shared paper, 2014 · strength 0.03
  21. Alexis B. Ulrich · 1 shared paper, 2014 · strength 0.03
  22. Sebastian Schölch · 1 shared paper, 2014 · strength 0.03
  23. Christian P. Pilarsky · 1 shared paper, 2014 · strength 0.03
  24. Werner Hartwig · 1 shared paper, 2011 · strength 0.03
  25. Nathan M. Mollberg · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.